Picture of Benitec Biopharma logo

BNTC Benitec Biopharma Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Benitec Biopharma, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2021
June 30th
2022
June 30th
2023
June 30th
2024
June 30th
2025
June 30th
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash
Cash and Equivalents
Cash and Short Term Investments19.84.062.4850.997.7
Net Total Accounts Receivable
Net Total Receivables0.0250.0030.0550.2290.033
Prepaid Expenses
Total Other Current Assets
Total Current Assets20.64.823.7351.798.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.5770.9930.6130.4490.991
Other Long Term Assets
Total Assets21.45.974.4652.299.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities1.372.533.984.921.8
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities1.373.094.264.962.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity202.880.20247.297.3
Total Liabilities & Shareholders' Equity21.45.974.4652.299.6
Total Common Shares Outstanding